Concert Pharmaceuticals logo
Concert Pharmaceuticals CNCE
$ 8.37 0.0%

Quarterly report 2022-Q3
added 11-07-2022

report update icon

Concert Pharmaceuticals EBITDA per Share 2011-2024 | CNCE

Annual EBITDA per Share Concert Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.21 -2.32 -3.32 -2.33 4.14 -2.26 1.21 -1.87 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.14 -3.32 -1.12

Quarterly EBITDA per Share Concert Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- -0.58 - -0.97 - -0.75 0.18 -0.7 -0.67 -0.58 -0.39 -0.63 -0.88 -0.71 -0.78 -0.85 -0.86 -0.7 -0.59 -0.15 -0.55 5.84 -0.55 -0.59 -0.54 -0.49 -0.59 -0.62 0.03 -0.37 1.93 -0.46 -0.48 -0.37 -0.39 -0.67 -4.3 -4.73 7.82 -0.61 - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.82 -4.73 -0.305